SEC Form 4 insider trading filings tracked in real time from EDGAR

Grossman William — Interim Chief Medical Officer

Insider trading activity for Grossman William sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Interim Chief Medical Officer
  • Company: enGene Therapeutics Inc.
  • Total insider trades: 7
  • Total buy volume: $10K
  • Total sell volume: $0
  • Last trade: Sep 24, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
Sep 22, 2026 Grossman William ENGN enGene Therapeutics Inc. BUY 5,102 $10K
Jun 16, 2026 Grossman William ENGN enGene Therapeutics Inc. OTHER 200,000 N/A
Jun 16, 2026 Grossman William ENGN enGene Therapeutics Inc. OTHER 31,000 N/A
Apr 23, 2026 Grossman William DAWN Day One Biopharmaceuticals, Inc. OTHER 15,000 N/A
Apr 23, 2026 Grossman William DAWN Day One Biopharmaceuticals, Inc. OTHER 22,500 N/A
Apr 23, 2026 Grossman William DAWN Day One Biopharmaceuticals, Inc. OTHER 32,335 N/A
Apr 23, 2026 Grossman William DAWN Day One Biopharmaceuticals, Inc. OTHER 66,660 N/A

← All executives · Full trades feed